Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

  1. San Miguel, J.F.
  2. Vidriales, M.B.
  3. López-Berges, C.
  4. Díaz-Mediavilla, J.
  5. Gutiérrez, N.
  6. Cañizo, C.
  7. Ramos, F.
  8. Pérez, J.J.
  9. González, M.
  10. Orfao, A.
Aldizkaria:
Blood

ISSN: 0006-4971

Argitalpen urtea: 2001

Alea: 98

Zenbakia: 6

Orrialdeak: 1746-1751

Mota: Artikulua

DOI: 10.1182/BLOOD.V98.6.1746 GOOGLE SCHOLAR lock_openSarbide irekia editor